UNSPSC 85822203: Measurement of peripheral nervous conductivity, motor, percutaneous approach

This classification denotes the group of activities that yields a measurement intervention or procedure to measurement of peripheral nervous conductivity, motor, percutaneous approach. This measurement intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 4A0132B

UNSPSC 85822203 Measurement of peripheral nervous conductivity, motor, percutaneous approach is a Commodity code that shows little relevant recent activity matching its nominal scope. The recent opportunities posted under this code involve virtual urgent care services, medical services contracting, Program of All Inclusive Care for the Elderly operations, rural value-based care facilitation, cancer registry services, handheld retinal screening devices, emergency medical technician staffing, occupational health clinics, histology lab services, travel nurse rosters, independent medical evaluations, EMS medical direction, physical exams and vaccinations, optical retail services, psychological testing, wellness platforms, recovery audit contracting, comprehensive wellness programs, nursing home placement beds, respirator medical exams, special education supplies, occupational health services, young adult recovery centers, EMS revenue billing, orthotic equipment, medical director agreements, cancer screening, employee wellness portals, opioid use disorder treatment and recovery services, youth crisis stabilization, day treatment programs, dual eligible special needs programs, health maintenance services, multisystemic therapy, opioid abatement programs, inmate health services, temporary health professional staffing, community health improvement initiatives, and radiology and EKG reads—none of which involves peripheral nervous system conductivity testing. The code's abstract specification does not align with the state and local health and social services procurement activity actually posted under it, suggesting a data-tagging mismatch rather than genuine market demand for peripheral nerve conduction measurement services at state and local level.

The recent opportunities span issuing bodies across multiple states and jurisdiction types, including state departments (Nevada Health Authority, Colorado Department of Human Services, Texas Health and Human Services Commission, Illinois Secretary of State, New Jersey Department of Health), counties (DeKalb, Forsyth, Jackson, San Mateo, Santa Clara, Solano, Ventura, Rockland, Cobb, Los Alamos, Harris, Washington), cities (Atlanta, Phoenix, Ocala), school districts (Parkway), regional authorities (Inland Empire Health Plan), and cooperative purchasing vehicles (Sourcewell, H-GAC, Region 7). No issuing body recurs frequently enough to suggest concentration. Geographic spread extends across California, Colorado, Georgia, Florida, Nevada, Texas, New Jersey, New York, Oregon, Virginia, Kansas, Missouri, Illinois, and Washington State, with no clear regional clustering. The absence of genuine peripheral nerve conductivity testing opportunities, combined with the breadth of unrelated health service solicitations, indicates the code is unsuitable for targeting and should not drive pursuit decisions.